Read More: eGenesis Announces World’s First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient


Julie Sunderland

Board Director

Ms. Julie Sunderland served as interim CEO of eGenesis from December 2017 through January 2019. She is managing director at Biomatics Capital Partners. Prior to co-founding Biomatics in 2016, Ms. Sunderland was director of Program Related Investments for the Bill & Melinda Gates Foundation, where she led the foundation’s $1.5 billion strategic investment pool focusing on global health, global development and education. In this role, she funded 50 investments, including 30 in health care, and built a team of 10 investment professionals.

Ms. Sunderland holds a B.A. from Harvard University, an MBA from Wharton Business School and an M.A. from Johns Hopkins School of Advanced International Studies.

Julie Sunderland